ConferenceBlood · November 3, 2025
AbstractIntroduction Acute myeloid leukemia (AML) with mutations in TP53 (TP53-Mut AML) is a high-risk disease with a dismal prognosis. How ...
Full textCite
ConferenceBlood · November 5, 2024
IntroductionSomatic TP53 mutations and 17p deletions resulting in the genomic loss of TP53 occur in 8% to 10% of de novo AML and are associated with ch ...
Full textCite